‹ÆÑW

‹ÆÑW

2001”N

‰¢•¶

˜a•¶Œ´’˜EÇ—á•ñ

˜a•¶‘à

’˜‘

Šw‰ï”­•\

Œ¤‹†•â•‹à

”ljï‹c•ñ

‚»‚Ì‘¼


‹ÆÑW–ÚŽŸ‚Ö

ŽóÜ—ð

‹ÆÑW

2001”N@‰¢•¶

Aihara Y, Inoue T, Tashiro T, Okmaoto K, Komiya Y and Mikoshiba Y (2001) Movement of endoplasmic reticulum in the living axon is distinct from other membranous vesicles in its rate, form and sensitivity towards microtuble inhibitors. J Neurosci Res. 65:236-246

Hayashi S, Sakurai A, Amari M and Okmaoto K (2001) Pathological study of the diffuse myelin pallor in the anterolateral columns of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 188:3-7

Kamiya M, Yamanouchi H, Yoshida T, Arai H, Yokoo H, Sasaki A, Hirato J, Nakazato Y, Sakazume Y and Okamoto K (2001) Ataxia telangiectasia with vascular abnormalities in the brain parenchyma: report of an autopsy case and literature review. Pathol Int 51:271-276

Mizuno Y, Thompson TG, Guyon JR, Lidov HGW, Brosius M, Imamura M, Ozawa E, Watkins SC, Kunkel LM (2001) Desmuslin, a novel intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci USA 98: 6156-6161

Mizuno Y, Puca AA, OfBrien KF, Beggs AH, Kunkel LM (2001) Genomic organization and single-nucleotide polymorphism map of desmuslin, a novel intermediate filament protein on chromosome 15q26.3. BMC Genet: 2-8

Okamoto K, Fujita Y, Aizawa H, Kusaka H and Mihara B (2001) Basophilic cytoplasmic incluisons in amyotrophic lateral sclerosis.In Molecular mechanism and therapeutics of amyotrophic lateral sclerosis ed. Abe K, Elsevier Science, PP21-26

Shoji M, Kanai M, Matsubara E, Tomidokoro Y, Shizuka M, Ikeda Y, Ikeda M, Harigaya Y, Okamoto K and Hirai S (2001) The levels of crebrospinal fluid A 40 and A 42(43) are regulated age-dependently. Neurobiol Aging 22:209-215

Sohmiya M, Tanaka M, Aihara Y, Hirai S and Okamoto K (2001) Age-related structural changes in the human midbrain. An MR image study. Neurobiol Aging 22:595-601

Takeda M, Tanaka T, Arai H, Sasaki H, Shoji M, Okamoto K, Urakami K, Nakashima K, Matsubayashi T, Sugita M and Yoshida H (2001)Basic and clinical studies on the measurement of ƒÀ-amyloid(1-42) in cerebrospinal fluids as a diagnostic marker for Alzheimer's disease and realted disorders: multi center study in Japan. Psychogeriatrics 1:56-63

Takenoshita H, Shizuka-Ikeda M, Song S-Y, Harigaya Y, Igeya Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H and Okmaoto K (2001) Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebelalr ataxia. J Neurol Neurosurg Psychiatry 70:386-389

Tomidokoro Y, Ishiguro K, Harigaya Y, Matsubara E, Ikeda M, Park JM, Yasutake K, Kawarabayashi T, Okmaoto K and SHoji M (2001) A amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett 299:169-172

Tomidokoro Y, Harigaya Y, Matsubara E, Ikeda M, Kawarabayashi T, Shirao T, Ishiguro K, Okamoto K, Younkin SG and Shoji M (2001) Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J Pathol 194:500-506

Yoshida T, Tanaka M and Okamoto K (2001) Inhibitory effect of nicergoline on superoxide generation by activated rat microglias measured using a simple chemiluminescence method. Neurosci Lett 297:5-8

ƒy[ƒW‚̐擪‚Ö